MERTK and colorectal cancer: scRNA-seq in human and mouse colorectal cancer identified a population of C1QC+ TAMs, characterized by high levels of C1QA/B/C, TREM2, and MERTK expression, which were associated with potential recruitment and activation of T cells, phagocytosis, and better prognosis (53, 56).